Capecitabine (Xeloda) offers a unique mode of action. The drug is currently being combined with other active agents in the treatment of advanced breast cancer. The recent demonstration of improved disease-free and overall
Daniel R. Budman, MD, FACP
Advertisement
Articles by Daniel R. Budman, MD, FACP
Advertisement
Latest Updated Articles
- New Directions With Capecitabine Combinations in Advanced Breast Cancer
Published: October 2nd 2002 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Managing BCMA/GPRC5D-Associated CRS and ICANS in the Real-World Setting
2
Adjuvant Endocrine/Radiation Therapy May Limit Breast Cancer Recurrence
3
Cryoablation Regimen Receives FDA Marketing Authorization for Breast Cancer
4
Addressing Early Talquetamab Toxicity Concerns
5
